secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001628280-24-002805
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q2 revenue up 12% to $57.4B; non-GAAP EPS $1.82 (+38%); FY24 guidance raised
--------------------------------------------------------------------------------

- GAAP diluted EPS $1.43 vs. $(0.50) prior year; non-GAAP operating earnings $562M, up 20%.
- Pharmaceutical segment profit $518M (+12%); Medical segment profit $71M vs. $17M.
- FY24 non-GAAP EPS guidance raised to $7.20-$7.35 from $6.75-$7.00; adj. free cash flow ~$2.5B.
- Announced acquisition of Specialty Networks, a tech-enabled multi-specialty GPO and practice enhancement organization.
- Revenue $57.4B, driven by brand/specialty pharmaceutical sales growth and COVID-19 vaccine distribution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/0001628280-24-002805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/cah-20240201.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-002805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer